about
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registryClinical review: Update on hemodynamic monitoring--a consensus of 16Albumin administration in the acutely ill: what is new and where next?Healthcare disparities in critical illnessProtocols in the management of critical illnessThe epidemiology of sepsis in the United States from 1979 through 2000Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.Conflicting clinical trial data: a lesson from albumin.Multifractal analysis for nutritional assessment.Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study.Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.Pulmonary vs nonpulmonary sepsis and mortality in acute lung injury.The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study.Marital status and the epidemiology and outcomes of sepsis.Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical TrialsVitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adultsSafety of research bronchoscopy in critically ill patientsThe role for invasive monitoring in acute lung injury.The effect of age on the development and outcome of adult sepsis.The epidemiology of sepsis in patients with malignancy.Alcohol abuse enhances pulmonary edema in acute respiratory distress syndrome.Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndromePatient factors associated with identification of sepsis in the ED.Epidemiology studies in critical careAnti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individualsWhat is old is new again: acetaminophen as a novel approach to treating sepsisState-of-the-art fluid management in critically ill patients.Vitamin D status and the risk for hospital-acquired infections in critically ill adults: a prospective cohort study.The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort.Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.Vitamin D deficiency is associated with anaemia among African Americans in a US cohort.Trends in the incidence of noncardiogenic acute respiratory failure: the role of racePrehospital recognition of severe sepsis: development and validation of a novel EMS screening tool.Albumin: biochemical properties and therapeutic potential.Vitamin D and sepsis: An emerging relationshipApplication of a Framework to Assess the Usefulness of Alternative Sepsis Criteria.Vitamin D in sepsis: from basic science to clinical impactUnited States Critical Illness and Injury Trials Group.Long-term survival following in-hospital cardiac arrest: A matched cohort study.Stem cells in sepsis and acute lung injury.
P50
Q21194917-D314F3B7-88C1-4968-A798-ABFE163397B6Q26849387-6A59C7DB-A095-4867-B5C7-2E040629677EQ26853626-E00F5F1D-A446-4F6D-942B-307DE14BA5C8Q26861647-EABE8C5F-8B9E-4F20-B7CE-8549DF791EFEQ27002502-A3648C8A-D612-4FB7-887F-5669E7DF9A70Q29547760-B35C52DB-68DB-420B-9D96-977F6DCCC606Q30483818-33687614-8594-4CD5-9D51-7638B4CD5DD8Q31026311-9C5F3C65-FD48-467A-AB7C-FE57B247E666Q31130295-0A8F343B-CF4F-4637-A069-B2796274B5F1Q33671517-8E0013CA-1AB0-41A9-B609-AD737B64F84DQ33713799-C7DBFA0A-6CAF-4F93-9D26-EED8471779C6Q33768016-F44A65B5-C4C9-4179-B5D7-B16B6329B56DQ33783333-A8E493AE-F132-4C9D-835B-3CFDD71ED093Q33897216-07D019B9-121A-4FF0-92DF-B87CA014D32EQ33956130-FFDB53C3-DEFB-4E4D-AA38-1EE8DE835147Q33969236-1AC9F180-5AA0-4F8A-8214-2A38FECB52F2Q34325089-34DB7D34-1ABD-47F4-B548-8E0F1943F98CQ34438236-A61B911D-AF09-4DE5-BB55-7CE819C130E8Q34479183-F9AEFB3B-6BD4-4A69-BFFF-0749C380029AQ34538810-899BFCB9-4CE3-44B6-A7A5-7C2D37423D17Q34561896-D0F00A48-5216-4A44-98E8-7458EFC75C82Q34718171-AB9CD9D2-1DE7-40D2-BE25-C1DA81FA3019Q34979854-0BB77B6D-13C3-464F-BB32-7205C95356EDQ34999366-38408398-05D9-4C5B-8155-9BE51DC212AAQ35095471-2F13BC6D-16E8-47D9-864F-494DE838D3F7Q35117244-BFE77C24-081B-4744-ACF3-FE2D38C88DF6Q35125287-404D607E-E60E-4B5C-B569-8FBDD5154B7DQ35303661-FDB52302-9D3C-4C84-B945-52CE6430226FQ35544749-7FBEEA8D-A182-4ED2-941D-79FD87542635Q35718231-75DB2864-B999-4705-99C3-30CB8564D87EQ35738401-7AD34857-25B1-4FE9-BEEA-C5A8EE023B40Q35897740-56DCB6E0-A4E3-4E9F-9989-8F11519523FFQ36037513-60E5E937-FA3E-4C05-81F7-732BFDF40FADQ36138540-00BA83FA-C75B-44CC-A4AD-C0214E31E384Q36187575-F70D5542-4FAA-4AF3-9F5B-181435B53E08Q36614155-B096FB87-4B95-4F45-96FF-12E7D0ACA1A2Q36633765-CC2B26BA-5CD1-4605-88AC-D24BF3D5D3CAQ36664405-599B6169-F87C-49F1-A4A6-B1964BB1E881Q36808891-9704E8DD-F894-4FA9-AE61-8E583FEBEAA5Q36916458-A794DAFA-DD21-4453-9752-5FC93893D88E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Greg S. Martin
@ast
Greg S. Martin
@en
Greg S. Martin
@es
Greg S. Martin
@nl
Greg S. Martin
@sl
type
label
Greg S. Martin
@ast
Greg S. Martin
@en
Greg S. Martin
@es
Greg S. Martin
@nl
Greg S. Martin
@sl
prefLabel
Greg S. Martin
@ast
Greg S. Martin
@en
Greg S. Martin
@es
Greg S. Martin
@nl
Greg S. Martin
@sl
P1053
B-4085-2009
P106
P108
P1153
8931642700
P21
P31
P3829
P496
0000-0002-9684-7593